Peptide cancervaccines Peptide vaccination for cancer immunotherapy represents a promising strategy to harness the body's own immune system to recognize and attack malignant cells作者：KY Tsang·被引用次数：7—Peptide vaccines can stimulate and activate T cells specific to tumor-associated antigens. Because peptides endogenously expressed by tumor cells are often weak .... These vaccines are designed based on specific epitope peptides, which are small fragments of proteins found on cancer cells.Peptide vaccines offer promise in cancer immunotherapy, leveraging specificity, safety, and the potential for targeted immune responses against tumors. By presenting these peptides to the immune system, the goal is to elicit a robust and targeted immune response, particularly activating T cells, to eliminate tumor cells. This approach offers a targeted method for cancer treatment, aiming to provide long-term acquired immunity with a comparatively low side-effect profile.作者：BA Shah·2025·被引用次数：13—Historically,peptide-based T cellvaccineshave been investigated as a potential strategy forcancer immunotherapy. Despite initial enthusiasm, ...
The development of peptide-based cancer vaccines is rooted in the understanding that the immune system, specifically cytotoxic T lymphocytes (CTLs), can be trained to identify and destroy cancer cells. Unlike some other cancer therapies, peptide vaccines aim to stimulate an endogenous immune response, utilizing the body's natural defenses. This method has shown great potential in cancer immunotherapy by targeting tumor antigens and activating the patient's immune system to fight the disease.
Peptide vaccines work by introducing specific peptide antigens that are derived from tumor-associated antigens (TAAs). These TAAs are proteins that are either overexpressed on cancer cells or are unique to themImproving the efficacy of peptide vaccines in cancer .... When these peptides are administered, they are processed by antigen-presenting cells (APCs), which then present them to T cells.Potential association factors for developing effective ... This presentation activates T cells, particularly CD8+ cytotoxic T lymphocytes (CTLs), which are crucial for killing cancer cells.Peptide Vaccines in Cancer Immunotherapy
The process involves several key steps:
* Antigen Identification: Researchers identify specific peptides that are characteristic of cancer cellsA 20-year-old cancer vaccine may hold the key to long- .... These can be derived from known tumor antigens or from neoantigens, which are mutations unique to a patient's tumor.Development of Peptide-Based Vaccines for Cancer - PMC
* Vaccine Formulation: The selected peptides are synthesized and formulated into a vaccine.Peptide-based vaccine for cancer therapies This often involves combining them with adjuvants, substances that enhance the immune response, to ensure a strong and effective reaction.
* Immune Activation: Upon administration, the peptides are taken up by APCs. These APCs then migrate to lymph nodes, where they present the peptide antigens to T cells.
* T Cell Response: This presentation primes T cells to recognize and target cancer cells displaying the same peptide antigens. The activated T cells then proliferate and travel to the tumor site to initiate an attack.
Significant progress has been made in the field of peptide vaccination, leading to its application in various cancer types and clinical trials. Personalized cancer vaccines, for instance, are being developed using neoantigen peptides specific to an individual's tumor. This personalized approach aims to maximize treatment efficacy by targeting the unique mutations present in a patient's cancer作者：JIE YANG·2015·被引用次数：35—The use ofpeptide‑basedvaccinesas therapeutics aims to elicit immune responses through antigenic epitopes derived from tumor antigens..
Synthetic long peptides (SLPs) are another area of advancement2016年5月26日—Synthetic long peptides (SLP) derived from cancer-associated antigenshold great promise as well-defined antigens for cancer immunotherapy.. These are longer peptide sequences that can more effectively mimic natural antigens and elicit stronger immune responsesCancer Vaccines Show Promise in Early Trials. They hold great promise as well-defined antigens for cancer immunotherapy.
Research is also exploring composite peptide-based vaccines and liposome-based formulations to enhance the delivery and immunogenicity of peptide vaccines.Peptide based vaccine design for cancer immunotherapy iscurrently being used in clinical trials for malignant melanomawith much success. These innovations aim to overcome some of the challenges associated with peptide vaccines, such as their immunogenicity and the potential for pre-existing immunity to vaccine peptides in some patients.
Despite the considerable promise of peptide vaccination, challenges remain作者：G Parmiani·2002·被引用次数：568—In this review, we analyze the available human TAApeptides, the potential immunogenicity (i.e., the ability to trigger a tumor-specific T-cell response) of TAA .... Optimizing the application of peptide vaccines in cancer immunotherapy is crucial to improve patient clinical outcomes作者：F Zahedipour·2023·被引用次数：27—Peptide vaccineshave shown great potential in cancer immunotherapyby targeting tumor antigens and activating the patient's immune system.. This includes refining vaccine design, identifying the most immunogenic peptides, and developing strategies to overcome immune tolerance or pre-existing immunity to cancer antigens作者：T Sasada·2012·被引用次数：44—We have developed a novel immunotherapeutic approach, personalizedpeptide vaccination(PPV), in which HLA-matchedpeptidesare selected and administered, based ....
Further research and clinical trials are required to fully understand the mechanisms of action, improve efficacy, and establish peptide vaccines as a standard treatment option. The integration of peptide vaccines with other immunotherapeutic approaches, such as checkpoint inhibitors, is also an active area of investigationPeptide-based vaccine for cancer therapies. The ultimate goal is to develop effective peptide vaccines that can provide durable anti-tumor immunity and improve long-term survival for cancer patients.
Join the newsletter to receive news, updates, new products and freebies in your inbox.